Authors
Bob Celeste, C4SCS
Latest:
DSCSA 2024 or 2023 Déjà Vu?A look at the challenges that need to be addressed during the FDA stabilization period.
Noelle Clifford
Latest:
Challenges in Cell and Gene Therapy Manufacturing, Sterility AssuranceManufacturers should leverage the knowledge base of personnel working in sterility assurance and in microbiology laboratories.
